The proposed condensation domain C* (CesA_C2) 8 transfers the hydroxy group of D- O -Leu-D-Ala- S -PCP to the thioester carbon of L- O -Val-L-Val- S -PCP to form an ester bond resulting in the PCP-bound tetradepsipeptide L- O -Val-L-Val-D- O -Leu-D-Ala- S -PCP ( DP4 ) 24 , which is subsequently transferred to the serine hydroxy group of the CesB C-terminal TE domain (Fig
The opposite is true in a YMYL category
Comparative effectiveness and use cases Modality selection should weigh indication and urgency of effect, comorbidities and medication burden, standardization and labeling requirements, scalability and access, and patient preference
Medical Conditions: If you have a history of blood disorders, liver disease, kidney problems, or cardiovascular conditions, discuss with your doctor before starting the supplement
European Journal of Endocrinology, 167(4), 465-471